161 related articles for article (PubMed ID: 5990418)
1. [Clinical and immunological prospective study of the measles live virus vaccine].
Sujoy E; Blaksley JC; Shepherd G; Simsolo V; Palais L; Pizzia A; Becker D; Behar M; Morgenstern O
Arch Argent Pediatr; 1966; 63(7):260-5. PubMed ID: 5990418
[No Abstract] [Full Text] [Related]
2. Studies on further attenuated live measles vaccine. IV. Clinical and serological evaluation of a clone of CAM-CEF measles vaccine virus.
Ueda S; Takahashi M; Kurimura T; Ogino T; Suzuki N
Biken J; 1970 Sep; 13(3):169-74. PubMed ID: 5530511
[No Abstract] [Full Text] [Related]
3. Studies on further attenuated live measles vaccine. 3. Selection of less reactive variants of CAM measles vaccine virus.
Takaku K; Sasada T; Konobe T; Onishi K; Ueda S
Biken J; 1970 Sep; 13(3):163-8. PubMed ID: 5530510
[No Abstract] [Full Text] [Related]
4. Development of extremely attenuated live measles virus vaccine (CAM-EX).
Ueda S; Takahashi M; Kurimura T; Minekawa Y; Suzuki N
Biken J; 1972 Sep; 15(3):173-7. PubMed ID: 4643692
[No Abstract] [Full Text] [Related]
5. [Clinical and immunological reactions after measles vaccination with cleavage vaccine and live vaccine].
Stehr K; Enders G; Suschke HJ; Spiess H
Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):383-7. PubMed ID: 5523685
[No Abstract] [Full Text] [Related]
6. Studies on further attenuated live measles vaccine. VIII. Estimated duration of immunity after vaccination without natural infection.
Ueda S; Okuno Y; Sakamoto Y; Sangkawibha N; Tuchinda P
Biken J; 1974 Mar; 17(1):11-20. PubMed ID: 4854462
[No Abstract] [Full Text] [Related]
7. [Study of clinical reactions and the fluctuation of antibody levels after measles vaccination. (1) Clinical reactions and serum antibody values after vaccination with raw vaccine only].
Kubota K
Nihon Shonika Gakkai Zasshi; 1967 Dec; 71(12):1478-83. PubMed ID: 4175590
[No Abstract] [Full Text] [Related]
8. [Comparative value of 3 anti-measles vaccines with attenuated live virus. Immuno-epidemiological study].
Topciu V; Arion R; Moldovan E; Csaky N; Olaru G
Arch Roum Pathol Exp Microbiol; 1971 Mar; 30(1):119-27. PubMed ID: 5096857
[No Abstract] [Full Text] [Related]
9. [Study on clinical reactions after inoculation of measles vaccine and transition of antibody values. 2. Clinical reactions with combination of inactivated raw vaccine and blood antibody value].
Kubota K
Nihon Shonika Gakkai Zasshi; 1968 Jan; 72(1):16-20. PubMed ID: 5691552
[No Abstract] [Full Text] [Related]
10. [Clinico-immunological characteristics of measles in children vaccinated with a live measles vaccine].
Smorodinova IP; Shikina ES
Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1973; 42():102-8. PubMed ID: 4808371
[No Abstract] [Full Text] [Related]
11. Studies on the combined use of killed and live measles vaccines. I. Correlation between antibody titers following injection of killed vaccine and clinical reactions after live vaccine inoculation.
Okuno Y; Ueda S; Hosai H; Kitawaki T; Nakamura K; Chiang TP; Okabe S; Onaka M; Toyoshima K
Biken J; 1965 Jun; 8(2):73-9. PubMed ID: 5837766
[No Abstract] [Full Text] [Related]
12. Investigation and application of the USSR AMS live measles vaccine from the ESC strain for mass vacceination against measles.
Chumakov MP; Voroshilova MK; Grachev VP; Sinyak KM; Boiko VM; Seibil VB; Rodin VI; Piven GG
Arch Roum Pathol Exp Microbiol; 1969; 28(2):651-67. PubMed ID: 5400784
[No Abstract] [Full Text] [Related]
13. [Specific prophylaxis in measles. II. Tests with children of a vaccine prepared with transformed live virus (strain M60-5 Huang)].
Cajal N; Cepleanu M; Sorodoc Y; Ionescu S; Gartner M; Ianopol L; Boghiţoiu G; Friedman O; Huluţă L; Ionescu D
Stud Cercet Inframicrobiol; 1966; 17(5):377-87. PubMed ID: 5964006
[No Abstract] [Full Text] [Related]
14. [Specific anti-measles prophylaxis in Rumania. 3. Comparative study of some live attenuated virus vaccines].
Cajal N; Cepleanu M; Cernescu C; Sorodoc Y
Stud Cercet Inframicrobiol; 1969; 20(4):275-85. PubMed ID: 5371258
[No Abstract] [Full Text] [Related]
15. [Activities of immune globulins at the time of measles vaccine inoculation and measles infection, with special reference to sensitivity and resistance of the antibody to 2-mercaptoethanol].
Arai M; Nakamura M
Nihon Shonika Gakkai Zasshi; 1969 Dec; 73(12):2032-7. PubMed ID: 4191839
[No Abstract] [Full Text] [Related]
16. [Study on clinical reactions after inoculation of measles vaccine and transition of antibody values. 3. Clinical figure of natural measles after inoculation of measles raw vaccine and the rise and fall of blood antibody values].
Kubota K
Nihon Shonika Gakkai Zasshi; 1968 Jan; 72(1):21-6. PubMed ID: 5691554
[No Abstract] [Full Text] [Related]
17. [Results of the first trials of measles vaccination in France, with the hyperattenuated live cirus vaccine (Schwartz strain)].
Mande R; Jammet ML; Celers J; Boué A
Arch Fr Pediatr; 1967 Jan; 24(1):105-6. PubMed ID: 6031447
[No Abstract] [Full Text] [Related]
18. [Comparative results of anti-measles serological immunity after the disease and after vaccination].
Topciu V; Moldovan E; Csaky N; Băcilă E
Arch Roum Pathol Exp Microbiol; 1970 Dec; 29(4):671-5. PubMed ID: 5521121
[No Abstract] [Full Text] [Related]
19. [Mass vaccination against measles in the Republic of Guatemala, 1972. Evaluation of the campaign].
Mata LJ; Aguilar FJ; Eddins DL; Herrmann KL; Nakano JH; Aguilar JR
Bol Med Hosp Infant Mex; 1974; 31(3):505-17. PubMed ID: 4433406
[No Abstract] [Full Text] [Related]
20. Studies on measles in Thailand. IV. Persistence of measles antibody in the absence of natural virus two years after vaccination by the "KL" method.
Sangkawibha N; Tsuchida P; Bukkavesa S; Ostanonda P; Ueda S
Biken J; 1971 Jun; 14(2):149-54. PubMed ID: 5122205
[No Abstract] [Full Text] [Related]
[Next] [New Search]
